Strategic Analysis of World Sleep Apnea Therapeutic MarketsFrost & SullivanMarch 8, 2004 SKU: MC968850 |
|
The Global Market for Medical Devices, 3rd. Edition
5/2/2012 | published by: Kalorama Information
Medical device makers faced a productive but challenging year in 2011. They innovated existing lines, launched new devices and invested in R&D. But they also experienced funding cutbacks and new taxes and regulations.
|
more...
|
$2,500.00
|
|
Calming and Sleeping in Latvia
5/8/2012 | published by: Euromonitor International
In Latvia, there was faster growth for standard calming and sleeping products in 2011. The shift towards more expensive and higher quality products was the major contributor to growth in 2011.The trend of younger consumers
|
more...
|
$900.00
|
|
Calming and Sleeping in Dominican Republic
5/9/2012 | published by: Euromonitor International
Calming and sleeping products are becoming increasingly popular due to the stressful lifestyles of consumers, especially those in large cities. Due to the speed of daily life, having to deal with different environments, work, family
|
more...
|
$900.00
|
|
Calming and Sleeping in Guatemala
5/10/2012 | published by: Euromonitor International
Use of OTC calming and sleeping products is limited in the country. The total market size of this category is GTQ850,800, making it one of the smallest categories in the consumer health market in the
|
more...
|
$900.00
|
|
Calming and Sleeping in Ukraine
5/10/2012 | published by: Euromonitor International
Consumers began to return to calming and sleeping products in 2011. The financial crisis contributed to increased usage of home-made traditional/herbal treatments (eg, valerian root) as a way to economise. However, as the economy showed
|
more...
|
$900.00
|
|
The Market for Home Care Products, 7th Edition
4/6/2012 | published by: Kalorama Information
This report, The Market for Home Care Products, 7th. Edition covers the market for products specially designed to assist with regular tasks of daily living. Growth in the ambulatory aids market continues to be driven
|
more...
|
$3,995.00
|
|
Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized
|
more...
|
$5,175.00
|
|
Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Each of these three individual parts is
|
more...
|
$5,175.00
|
|
Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Peptides
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Peptides). Each of these three individual parts is
|
more...
|
$5,175.00
|
|
Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 provides data on the Bronchopulmonary Dysplasia clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
Related Markets
- Diseases & Conditions
- Insomnia & Sleep Disorders
- Medical Devices
- Respiratory Devices
- Therapeutic Area
- Respiratory/Pulmonary
